Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.
about
Erythropoiesis-stimulating agents for anaemia in chronic heart failure patientsVentricular assist devices: pharmacological aspects of a mechanical therapyAnemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial FibrillationThreshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysisAcute Heart Failure Registry: Risk Assessment Model in Decompensated Heart FailurePharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.Pathophysiology of Heart Failure.The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction.Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats.Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial.Savoring every drop - vampire or mosquito?Managing anemia in patients with chronic heart failure: what do we know?Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questionsPreoperative anemia increases mortality and postoperative morbidity after cardiac surgery.Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia.Recovery from anemia in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation--prevalence, predictors and clinical outcomeThe relationship between Type D personality, affective symptoms and hemoglobin levels in chronic heart failureESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with theThe impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction.The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysisMechanisms linking red blood cell disorders and cardiovascular diseasesIron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammationAnemia and heart failure: a cause of progression or only a consequence?Anemia in heart failure patientsAnemia as an Independent Predictor of Adverse Cardiac Outcomes in Patients with Atrial FibrillationPrevalence of anaemia among patients with heart failure at the Brazzaville University HospitalSequential organ failure assessment score predicts mortality after coronary artery bypass grafting.Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy.Erythropoietin update 2011Anemia associated with chronic heart failure: current concepts.Effect of transfusion on dizziness in anemic patients after elective off-pump coronary artery bypass graft surgery.Maternal Myocardial Performance in Second Trimester of Pregnancy With Iron Deficiency Anaemia.Anemia and heart failure: a community study.Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions.Etiology and management of anemia in patients with heart failure: how much iron is missing?Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
P2860
Q24241045-DC354DBC-0705-4E6B-9BC8-8473935AA26BQ27002612-1934FB2F-681A-4DB2-B9E2-6152A6F83D8BQ28073527-7915BD1F-2060-4504-8803-AFC032B1CF7FQ28744139-F619B585-EA30-4B38-8DD6-FAE5872B3213Q30100975-13629D8C-558D-4387-80B8-FC5893EF1CF5Q30250020-A6F9088D-5710-4A16-81EA-9038C7DD9ABBQ30315815-4BBCF030-D435-4482-98D0-77CD17661D45Q30475623-5AF24BC9-7F0B-4423-A3FF-6812890916F2Q30952502-D9122CC9-8EC5-48C9-B649-50284EC9A732Q33364402-033D36DB-51D8-41A9-A7F9-509C75459EBFQ33726150-9CF03DD4-72FA-4A93-86C6-B4AD16937951Q33752207-4DDAA143-48C0-4FB0-957B-5C713BA9073AQ33797640-E09AD155-4919-4FF0-A28C-D981B30EAA1EQ34064046-D3A6B2B4-5A96-42FC-99C8-CA5EA0B46652Q34065957-D9C2D4E6-7513-4EA7-BE26-5E0F2634A255Q34544518-B12C7E0A-089A-4082-B3E3-C2EAE5B5DC81Q34576103-4C351B5B-0679-411A-B638-73EDCB38939DQ34589200-8631F791-A8EC-405F-B538-7BDD2C223865Q34601843-CB3ACCDB-6B31-4108-B6E1-25A1BDC8A0B4Q34614964-6D484E93-81CB-4567-B811-8C76190A5B6AQ34830023-5E38F15F-DB4A-4CF1-83F5-2F1D6910B4F1Q35072339-B5310CF4-5566-4777-8AA7-F641FAC9574BQ35088131-3AE3543D-013D-403C-88AF-5EA45BFC2B4EQ35091967-90767A88-5890-43C0-83B5-5E2A446F7739Q35234274-CE5A4BBF-9E22-43D5-BAE7-DBA7F8D572E6Q35252704-9A402052-9F10-40DD-AADB-CBF05B392B88Q35872198-A0AB9AA5-9F58-44EC-B45D-744F8F22EF8FQ35942115-E032F4AA-7E8B-427A-9E68-16FDC61B4757Q35962136-B8D55862-0BAA-480D-BD2D-FC9C480F40D6Q36298792-7191075E-6DAA-4A1E-BDCA-2215ED872D73Q36412620-518F483E-1C1D-47CF-887D-8AAAE7645478Q36425227-8F2E5433-4486-4A56-BE33-E2F1D8B82BADQ36516298-D3AA4A29-AD41-4AB4-9902-0F29F1D1D78BQ36600453-2DA320AB-91E6-42E6-9035-9656C76213F4Q36732687-0A3EF191-3C35-4328-B0DA-23240E6CEE5AQ36830984-0474D831-FBE5-4589-B05F-1A599D29D645Q36882168-12583FFA-AF1B-4ABC-8631-994C493A81CCQ36973213-7EE913DB-E5A7-47AD-9441-4B256560D817Q37078810-442CA554-4691-4ADC-97C8-DBF37C9F9211Q37250239-F4259229-F63D-497A-A479-104B1BBFCB94
P2860
Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Anemia in chronic heart failur ...... elates, and treatment options.
@ast
Anemia in chronic heart failur ...... elates, and treatment options.
@en
type
label
Anemia in chronic heart failur ...... elates, and treatment options.
@ast
Anemia in chronic heart failur ...... elates, and treatment options.
@en
prefLabel
Anemia in chronic heart failur ...... elates, and treatment options.
@ast
Anemia in chronic heart failur ...... elates, and treatment options.
@en
P1433
P1476
Anemia in chronic heart failur ...... elates, and treatment options.
@en
P2093
Stuart D Katz
Yi-Da Tang
P304
P356
10.1161/CIRCULATIONAHA.105.583666
P407
P577
2006-05-01T00:00:00Z